Growth Equity Opportunities V LLC 13D and 13G filings for MEI Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-03-09 4:10 pm Sale | 2023-03-09 | 13D | MEI Pharma, Inc. MEIP | Growth Equity Opportunities V LLC | 0 0.000% | -498,161![]() (Position Closed) | Filing |